Menten AI

📍 San Francisco, United States🗓 Founded 2018👥 14 employees💰 Last funded Sep 2022
Biotechnology Research🌐 menten.ai
Website LinkedIn
Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the worlds most advanced generative AI platform for peptide therapeutics.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2020–2022 · investors recorded per year
2020220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Menten AI?
Menten AI has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Menten AI last raise funding?
The most recent investment in Menten AI recorded on gritt.io was in September 2022.
When was Menten AI founded?
Menten AI was founded in 2018.
What industry is Menten AI in?
Menten AI operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Menten AI based?
Menten AI is headquartered in San Francisco, United States.